Dermatology

Conditions

• Atopic dermatitis
• Psoriasis
• Actinic keratosis
• Acne
• Other skin conditions
  • Onychomycosis
  • Alopecia areata
  • Keratinocyte cancer
  • Vitiligo
  • Hidradenitis suppurativa
  • Rare skin diseases

Innovation

Innovating in medical dermatology to improve patients’ lives

Inspired by science and devoted to patients.

Leading with scientific innovation in dermatology

Driven by science, focused on patients

In 2024, we invested 12% of annual net sales in R&D. Our DNA is built on scientific rigour and genuine care for patients. By consistently investing a significant share of our resources in research and development, we work to bring forward medicines that have a meaningful impact across a broad spectrum of skin conditions. Our goal is not only to treat symptoms, but also to improve long-term outcomes and quality of life.

5.1% of workforce dedicated to R&D

With 5.1% of our workforce – 267 highly specialised scientists – dedicated to R&D, we are able to explore new ideas, technologies and modes of treatment at pace. We listen carefully to patients, caregivers and healthcare professionals to understand both the physical burden and emotional impact of skin diseases. These insights guide our research, helping us to anticipate future needs and to co-create solutions with leading academic institutions and industry partners.

Our way of doing R&D

We currently help to improve the lives of millions of people in more than 100 countries. Our cutting-edge R&D centre in Sant Feliu de Llobregat (Barcelona, Spain) brings together multidisciplinary teams who collaborate closely to move discoveries efficiently from the laboratory to the clinic. By combining robust science, advanced technology and strong external partnerships, we strive to deliver breakthrough dermatology treatments that address unmet medical needs and raise the standard of care.

R&D Capabilities and facilities

Our R&D facilities are equipped with modern laboratories, specialised technologies and integrated digital tools that support high-quality, data-driven research.

From molecular biology and translational science to pharmacology, clinical development and real-world evidence, our capabilities enable us to generate robust insights at every stage of development.

This comprehensive infrastructure allows us to accelerate innovation while maintaining the highest scientific and ethical standards.

Partnerships

We collaborate with suppliers, research organisations, start-ups and established industry leaders to expand our reach and capabilities. By building long-term, trust-based partnerships, we share expertise, strengthen our supply chain and ensure that innovative treatments are developed, manufactured and delivered reliably and responsibly to the people who need them most.

Our Team

Julia Valls

Clinical Development Scientist
“We believe innovation starts by listening. In our design forums, diverse perspectives come together to shape innovative, patient‑centric studies with robust outcomes.”

Marie-Helene Larraufie

Director, Molecular and Cell Biology “What makes this environment so exciting for me as a scientist is that our pipeline already reflects early ideas that will help patients in the future.”

Clinical Trials

Our commitment to patients. A clinical trial is a research study where patients help evaluate the safety and effectiveness of new treatments.

If you’re interested in contributing to medical progress, consider exploring our clinical trials to see whether there’s a study you may be eligible to join.

Do you know how to take care of your skin?

At Almirall, we care about the overall effect that living with a skin condition may have on patients and their families. Find out all of our well-being recommendations, beyond treating symptoms, and discover all of our resources.

Connect, learn and lead

Through collaborative dialogue and cutting-edge insights, we empower our community to navigate change boldly and shape the future of patient care worldwide.